Caligan Partners LP - 26 Dec 2025 SCHEDULE 13D/A Report for Verrica Pharmaceuticals Inc. Common Stock, par value $0.0001 per share (VRCA)

Filing Manager: Caligan Partners LP
Reporting Manager: Caligan Partners LP
Security: Verrica Pharmaceuticals Inc. Common Stock, par value $0.0001 per share
Symbol: VRCA
Shares outstanding: 65,095,636 shares
Disclosed Ownership: 6,503,054 shares
Ownership: 10%
Form type: SCHEDULE 13D/A
Filing time: 30 Dec 2025, 07:10:47 UTC
Date of event: 26 Dec 2025
Previous filing: 24 Nov 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Caligan Partners LP	10%	6,503,054	0	6,503,054	/s/ David Johnson	David Johnson, Managing Partner	0001727492
David Johnson	10%	6,503,054	0	6,503,054	/s/ David Johnson	David Johnson, Individually	0001785557